Below is Validea's guru fundamental report for SOLENO THERAPEUTICS INC (SLNO). Of the 22 guru strategies we follow, SLNO rates highest using our P/B Growth Investor model based on the published ...

In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other stocks that jumped, defying market uncertainties on Thursday. The stock market ...

Soleno Therapeutics (SLNO) announced the U.S. commercial availability of VYKAT XR extended-release tablets, the company’s treatment for ...

In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other firms that end Friday strong. Wall Street’s main indices finished the trading ...

In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other stocks that jumped, defying market uncertainties on Thursday. The stock market ...

Soleno Therapeutics (SLNO) stock skyrocketed up over 42% this past week on news that it has achieved a significant milestone with FDA approval for VYKAT XR, a pioneering treatment for hyperphagia ...

Highlights:,Insider transactions have been observed within Soleno Therapeutics, with key executives reducing personal holdings.,Analysts from multiple firms have adjusted their outlook on the company, ...

Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) – HC Wainwright boosted their Q1 2025 earnings estimates for shares of Soleno Therapeutics in a report released on Monday, March 31st.HC ...

Shares of Soleno Therapeutics SLNO have rallied 37% in the premarket hours today following the FDA approval of Vykat XR (diazoxide choline) extended-release tablets for treating hyperphagia in ...

In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other stocks that outperformed broader market last week. Wall Street’s main indices ...